Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 316

1.

Efficacy of imatinib and chemotherapy in a pediatric patient with Philadelphia-like acute lymphoblastic leukemia with Ebf1-Pdgfrb fusion transcript.

Fazio F, Barberi W, Cazzaniga G, Fazio G, Messina M, Della Starza I, De Propris MS, Mancini F, Mohamed S, Del Giudice I, Chiaretti S, Moleti ML, Guarini A, Foà R, Testi AM.

Leuk Lymphoma. 2019 Sep 27:1-4. doi: 10.1080/10428194.2019.1668938. [Epub ahead of print] No abstract available.

PMID:
31558067
2.

Minimal Residual Disease in Chronic Lymphocytic Leukemia: A New Goal?

Del Giudice I, Raponi S, Della Starza I, De Propris MS, Cavalli M, De Novi LA, Cappelli LV, Ilari C, Cafforio L, Guarini A, Foà R.

Front Oncol. 2019 Aug 29;9:689. doi: 10.3389/fonc.2019.00689. eCollection 2019. Review.

3.

Integrated gastroenterology and rheumatology ambulatory: an innovative approach for enteropathic spondyloarthritis early diagnosis.

Lorenzetti R, Scolieri P, Guarini A, De Marinis F, Zullo A, Hassan C; Italian Society of Gastro-Rheumatology, Bruzzese V.

Ann Ist Super Sanita. 2019 Jul-Sep;55(3):246-248. doi: 10.4415/ANN_19_03_08.

4.

Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue.

Ciavarella S, Vegliante MC, Fabbri M, De Summa S, Melle F, Motta G, De Iuliis V, Opinto G, Enjuanes A, Rega S, Gulino A, Agostinelli C, Scattone A, Tommasi S, Mangia A, Mele F, Simone G, Zito AF, Ingravallo G, Vitolo U, Chiappella A, Tarella C, Gianni AM, Rambaldi A, Zinzani PL, Casadei B, Derenzini E, Loseto G, Pileri A, Tabanelli V, Fiori S, Rivas-Delgado A, López-Guillermo A, Venesio T, Sapino A, Campo E, Tripodo C, Guarini A, Pileri SA.

Ann Oncol. 2019 Sep 20. pii: mdz386. doi: 10.1093/annonc/mdz386. [Epub ahead of print] No abstract available.

PMID:
31539020
5.

Minimal Residual Disease in Acute Lymphoblastic Leukemia: Technical and Clinical Advances.

Della Starza I, Chiaretti S, De Propris MS, Elia L, Cavalli M, De Novi LA, Soscia R, Messina M, Vitale A, Guarini A, Foà R.

Front Oncol. 2019 Aug 7;9:726. doi: 10.3389/fonc.2019.00726. eCollection 2019. Review.

6.

How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis.

Galvano A, Incorvaia L, Badalamenti G, Rizzo S, Guarini A, Cusenza S, Castellana L, Barraco N, Calò V, Cutaia S, Currò G, Silvestris N, Beretta GD, Bazan V, Russo A.

Cancers (Basel). 2019 Aug 15;11(8). pii: E1189. doi: 10.3390/cancers11081189. Review.

7.

Moral Disengagement and Risk Prototypes in the Context of Adolescent Cyberbullying: Findings From Two Countries.

Lazuras L, Brighi A, Barkoukis V, Guarini A, Tsorbatzoudis H, Genta ML.

Front Psychol. 2019 Aug 8;10:1823. doi: 10.3389/fpsyg.2019.01823. eCollection 2019.

8.

Minimal residual disease monitoring in early stage follicular lymphoma can predict prognosis and drive treatment with rituximab after radiotherapy.

Pulsoni A, Della Starza I, Cappelli LV, Tosti ME, Annechini G, Cavalli M, De Novi LA, D'Elia GM, Grapulin L, Guarini A, Del Giudice I, Foà R.

Br J Haematol. 2019 Aug 5. doi: 10.1111/bjh.16125. [Epub ahead of print]

PMID:
31385309
9.

Long-Lasting Remission in De Novo Breast Myeloid Sarcoma Treated with Decitabine and Radiotherapy.

Minoia C, de Fazio V, Scognamillo G, Scattone A, Maggialetti N, Ferrari C, Guarini A.

Diagnostics (Basel). 2019 Jul 27;9(3). pii: E84. doi: 10.3390/diagnostics9030084.

10.

Young, Bullying, and Connected. Common Pathways to Cyberbullying and Problematic Internet Use in Adolescence.

Brighi A, Menin D, Skrzypiec G, Guarini A.

Front Psychol. 2019 Jul 4;10:1467. doi: 10.3389/fpsyg.2019.01467. eCollection 2019.

11.

Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network.

Della Starza I, Cavalli M, De Novi LA, Genuardi E, Mantoan B, Drandi D, Barbero D, Ciabatti E, Grassi S, Gazzola A, Mannu C, Agostinelli C, Piccaluga PP, Bomben R, Degan M, Gattei V, Guarini A, Foà R, Galimberti S, Ladetto M, Ferrero S, Del Giudice I; Fondazione Italiana Linfomi (FIL) MRD Network.

Hematol Oncol. 2019 Jul 19. doi: 10.1002/hon.2652. [Epub ahead of print]

PMID:
31325190
12.

Digital droplet PCR at the time of TKI discontinuation in chronic-phase chronic myeloid leukemia patients is predictive of treatment-free remission outcome.

Colafigli G, Scalzulli E, Porrazzo M, Diverio D, Loglisci MG, Latagliata R, Guarini A, Foà R, Breccia M.

Hematol Oncol. 2019 Jul 19. doi: 10.1002/hon.2650. [Epub ahead of print] No abstract available.

PMID:
31321792
13.

Effects of Physical Exercise Intervention on Psychological and Physical Fitness in Lymphoma Patients.

Fischetti F, Greco G, Cataldi S, Minoia C, Loseto G, Guarini A.

Medicina (Kaunas). 2019 Jul 16;55(7). pii: E379. doi: 10.3390/medicina55070379.

14.

Use of a single-step approach for integrating foreign information into national genomic evaluation in Holstein cattle.

Guarini AR, Lourenco DAL, Brito LF, Sargolzaei M, Baes CF, Miglior F, Tsuruta S, Misztal I, Schenkel FS.

J Dairy Sci. 2019 Sep;102(9):8175-8183. doi: 10.3168/jds.2018-15819. Epub 2019 Jul 10.

PMID:
31301840
15.

Real world Italian experience of pomalidomide plus low-dose dexamethasone in the relapsed and refractory myeloma setting: extended follow-up of a retrospective multicenter study by the 'Rete Ematologica Pugliese E Basilicata'.

Mele G, Pastore D, Di Renzo N, Fragasso A, Guarini A, Mazza P, Musto P, Pavone V, Tarantini G, Curci P, Falcone AP, Mele A, Miccolis MR, Palazzo G, Palumbo G, Quinto AM, Reddiconto G, Rizzi R, Cascavilla N, Specchia G, Capalbo SF.

Leuk Lymphoma. 2019 Jul 9:1-4. doi: 10.1080/10428194.2019.1636989. [Epub ahead of print] No abstract available.

PMID:
31286780
16.

The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia.

Visentin A, Bonaldi L, Rigolin GM, Mauro FR, Martines A, Frezzato F, Imbergamo S, Scomazzon E, Pravato S, Bardi MA, Cavallari M, Volta E, Cavazzini F, Nanni M, Del Giudice I, Facco M, Guarini A, Semenzato G, Foà R, Cuneo A, Trentin L.

Br J Cancer. 2019 Jul;121(2):150-156. doi: 10.1038/s41416-019-0502-x. Epub 2019 Jun 18.

PMID:
31209327
17.

An update on the conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting TKI-based therapy.

Galvano A, Guarini A, Iacono F, Castiglia M, Rizzo S, Tarantini L, Gori S, Novo G, Bazan V, Russo A.

Expert Opin Drug Saf. 2019 Jun;18(6):485-496. doi: 10.1080/14740338.2019.1613371. Epub 2019 May 7. Review.

PMID:
31062991
18.

Digital droplet PCR and next-generation sequencing refine minimal residual disease monitoring in acute lymphoblastic leukemia.

Della Starza I, De Novi LA, Santoro A, Salemi D, Tam W, Cavalli M, Menale L, Soscia R, Apicella V, Ilari C, Vitale A, Testi AM, Inghirami G, Chiaretti S, Foà R, Guarini A.

Leuk Lymphoma. 2019 May 3:1-3. doi: 10.1080/10428194.2019.1607325. [Epub ahead of print] No abstract available.

PMID:
31050551
19.

Estimating the effect of the deleterious recessive haplotypes AH1 and AH2 on reproduction performance of Ayrshire cattle.

Guarini AR, Sargolzaei M, Brito LF, Kroezen V, Lourenco DAL, Baes CF, Miglior F, Cole JB, Schenkel FS.

J Dairy Sci. 2019 Jun;102(6):5315-5322. doi: 10.3168/jds.2018-15366. Epub 2019 Apr 4.

PMID:
30954262
20.

RPC Teacher-Based Program for Improving Coping Strategies to Deal with Cyberbullying.

Guarini A, Menin D, Menabò L, Brighi A.

Int J Environ Res Public Health. 2019 Mar 16;16(6). pii: E948. doi: 10.3390/ijerph16060948.

21.

The profile of very preterm children on academic achievement. A cross-population comparison with children with specific learning disorders.

Guarini A, Bonifacci P, Tobia V, Alessandroni R, Faldella G, Sansavini A.

Res Dev Disabil. 2019 Apr;87:54-63. doi: 10.1016/j.ridd.2019.02.001. Epub 2019 Feb 15.

PMID:
30772706
22.

Synthesis and biological evaluation of N-biphenyl-nicotinic based moiety compounds: A new class of antimitotic agents for the treatment of Hodgkin Lymphoma.

Porcelli L, Stolfa D, Stefanachi A, Di Fonte R, Garofoli M, Iacobazzi RM, Silvestris N, Guarini A, Cellamare S, Azzariti A.

Cancer Lett. 2019 Mar 31;445:1-10. doi: 10.1016/j.canlet.2018.12.013. Epub 2018 Dec 22.

PMID:
30583077
23.

Genetics and genomics of reproductive disorders in Canadian Holstein cattle.

Guarini AR, Lourenco DAL, Brito LF, Sargolzaei M, Baes CF, Miglior F, Misztal I, Schenkel FS.

J Dairy Sci. 2019 Feb;102(2):1341-1353. doi: 10.3168/jds.2018-15038. Epub 2018 Nov 22.

PMID:
30471913
24.

Unravelling the suboptimal response of TP53-mutated chronic lymphocytic leukaemia to ibrutinib.

Guarini A, Peragine N, Messina M, Marinelli M, Ilari C, Cafforio L, Raponi S, Bonina S, Mariglia P, Mauro FR, Gaidano G, Del Giudice I, Foà R.

Br J Haematol. 2019 Feb;184(3):392-396. doi: 10.1111/bjh.15613. Epub 2018 Oct 18.

PMID:
30338509
25.

Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue.

Ciavarella S, Vegliante MC, Fabbri M, De Summa S, Melle F, Motta G, De Iuliis V, Opinto G, Enjuanes A, Rega S, Gulino A, Agostinelli C, Scattone A, Tommasi S, Mangia A, Mele F, Simone G, Zito AF, Ingravallo G, Vitolo U, Chiappella A, Tarella C, Gianni AM, Rambaldi A, Zinzani PL, Casadei B, Derenzini E, Loseto G, Pileri A, Tabanelli V, Fiori S, Rivas-Delgado A, López-Guillermo A, Venesio T, Sapino A, Campo E, Tripodo C, Guarini A, Pileri SA.

Ann Oncol. 2018 Dec 1;29(12):2363-2370. doi: 10.1093/annonc/mdy450.

26.

Does early object exploration support gesture and language development in extremely preterm infants and full-term infants?

Zuccarini M, Guarini A, Iverson JM, Benassi E, Savini S, Alessandroni R, Faldella G, Sansavini A.

J Commun Disord. 2018 Nov - Dec;76:91-100. doi: 10.1016/j.jcomdis.2018.09.004. Epub 2018 Sep 28.

27.

Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.

Fedullo AL, Messina M, Elia L, Piciocchi A, Gianfelici V, Lauretti A, Soddu S, Puzzolo MC, Minotti C, Ferrara F, Martino B, Chiusolo P, Calafiore V, Paolini S, Vignetti M, Vitale A, Guarini A, Foà R, Chiaretti S.

Haematologica. 2019 Feb;104(2):312-318. doi: 10.3324/haematol.2018.196055. Epub 2018 Sep 6.

28.

IL7R overexpression in adult acute lymphoblastic leukemia is associated to JAK/STAT pathway mutations and identifies patients who could benefit from targeted therapies.

Gianfelici V, Messina M, Paoloni F, Peragine N, Lauretti A, Fedullo AL, Di Giacomo F, Vignetti M, Vitale A, Guarini A, Chiaretti S, Foà R.

Leuk Lymphoma. 2019 Mar;60(3):829-832. doi: 10.1080/10428194.2018.1499906. Epub 2018 Sep 6. No abstract available.

PMID:
30188230
29.

Self-reported harm of adolescent peer aggression in three world regions.

Skrzypiec G, Alinsug E, Nasiruddin UA, Andreou E, Brighi A, Didaskalou E, Guarini A, Kang SW, Kaur K, Kwon S, Ortega-Ruiz R, Romera EM, Roussi-Vergou C, Sandhu D, Sikorska I, Wyra M, Yang CC.

Child Abuse Negl. 2018 Nov;85:101-117. doi: 10.1016/j.chiabu.2018.07.030. Epub 2018 Aug 28.

PMID:
30170922
30.

Brentuximab vedotin as salvage treatment in Hodgkin lymphoma naïve transplant patients or failing ASCT: the real life experience of Rete Ematologica Pugliese (REP).

Pavone V, Mele A, Carlino D, Specchia G, Gaudio F, Perrone T, Mazza P, Palazzo G, Guarini A, Loseto G, Eleonora P, Cascavilla N, Scalzulli P, Melpignano A, Quintana G, Di Renzo N, Tarantini G, Capalbo S.

Ann Hematol. 2018 Oct;97(10):1817-1824. doi: 10.1007/s00277-018-3379-5. Epub 2018 Jul 27.

PMID:
30054707
31.

Autologous stem cell transplant in acute lymphoblastic leukemia: prognostic impact of pre-transplant minimal residual disease.

Capria S, Pepe S, Trisolini SM, Testi AM, Vitale A, De Propris MS, Della Starza I, Elia L, Guarini A, Chiaretti S, Foà R.

Leuk Lymphoma. 2019 Jan;60(1):274-276. doi: 10.1080/10428194.2018.1468895. Epub 2018 Jun 26. No abstract available.

PMID:
29944039
32.

Comparison of genomic predictions for lowly heritable traits using multi-step and single-step genomic best linear unbiased predictor in Holstein cattle.

Guarini AR, Lourenco DAL, Brito LF, Sargolzaei M, Baes CF, Miglior F, Misztal I, Schenkel FS.

J Dairy Sci. 2018 Sep;101(9):8076-8086. doi: 10.3168/jds.2017-14193. Epub 2018 Jun 21.

33.

Improvable Lifestyle Factors in Lymphoma Survivors.

Minoia C, Ciavarella S, Lerario G, Daniele A, De Summa S, Napolitano M, Guarini A.

Acta Haematol. 2018;139(4):235-237. doi: 10.1159/000489252. Epub 2018 Jun 21. No abstract available.

PMID:
29929199
34.

High concordance between trained nurses and gastroenterologists in evaluating recordings of small bowel video capsule endoscopy (VCE).

Guarini A, De Marinis F, Hassan C, Manta R, De Francesco V, Annibale B, Zullo A.

J Gastrointestin Liver Dis. 2018 Jun;27(2):271. doi: 10.15403/jgld.2014.1121.272.bch.

PMID:
29922756
35.

Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease.

Raponi S, Del Giudice I, Ilari C, Cafforio L, Messina M, Cappelli LV, Bonina S, Piciocchi A, Marinelli M, Peragine N, Mariglia P, Mauro FR, Rigolin GM, Rossi F, Bomben R, Dal Bo M, Del Poeta G, Diop F, Favini C, Rossi D, Gaidano G, Cuneo A, Gattei V, Guarini A, Foá R.

Br J Haematol. 2019 Apr;185(1):156-159. doi: 10.1111/bjh.15405. Epub 2018 May 22. No abstract available.

PMID:
29785734
36.

Rapid identification of BCR/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implications.

Chiaretti S, Messina M, Grammatico S, Piciocchi A, Fedullo AL, Di Giacomo F, Peragine N, Gianfelici V, Lauretti A, Bareja R, Martelli MP, Vignetti M, Apicella V, Vitale A, Li LS, Salek C, Elemento O, Inghirami G, Weinstock DM, Guarini A, Foà R.

Br J Haematol. 2018 Jun;181(5):642-652. doi: 10.1111/bjh.15251. Epub 2018 Apr 19.

37.

Tailoring CD19xCD3-DART exposure enhances T-cells to eradication of B-cell neoplasms.

Circosta P, Elia AR, Landra I, Machiorlatti R, Todaro M, Aliberti S, Brusa D, Deaglio S, Chiaretti S, Bruna R, Gottardi D, Massaia M, Giacomo FD, Guarini AR, Foà R, Kyriakides PW, Bareja R, Elemento O, Chichili GR, Monteleone E, Moore PA, Johnson S, Bonvini E, Cignetti A, Inghirami G.

Oncoimmunology. 2018 Feb 8;7(4):e1341032. doi: 10.1080/2162402X.2017.1341032. eCollection 2018.

38.

Life for patients with myelofibrosis: the physical, emotional and financial impact, collected using narrative medicine-Results from the Italian 'Back to Life' project.

Palandri F, Benevolo G, Iurlo A, Abruzzese E, Carella AM, Paoli C, Palumbo GA, Bonifacio M, Cilloni D, Andriani A, Guarini A, Turri D, Elli EM, Falcone A, Anaclerico B, Musto P, Di Renzo N, Tiribelli M, Zambello R, Spinosa C, Ricco A, Raucci L, Martino B, Annunziata M, Pascale S, Liberati AM, La Nasa G, Maffioli M, Breccia M, Pugliese N, Betti S, Giglio G, Cappuccio A, Reale L.

Qual Life Res. 2018 Jun;27(6):1545-1554. doi: 10.1007/s11136-018-1827-2. Epub 2018 Mar 8.

PMID:
29520559
39.

Comparing deregression methods for genomic prediction of test-day traits in dairy cattle.

de Oliveira HR, Silva FF, Brito LF, Guarini AR, Jamrozik J, Schenkel FS.

J Anim Breed Genet. 2018 Apr;135(2):97-106. doi: 10.1111/jbg.12317. Epub 2018 Feb 26.

PMID:
29484718
40.

Prognostic factors associated with a stable MR4.5 achievement in chronic myeloid leukemia patients treated with imatinib.

Breccia M, Molica M, Colafigli G, Massaro F, Quattrocchi L, Latagliata R, Mancini M, Diverio D, Guarini A, Alimena G, Foà R.

Oncotarget. 2017 Dec 26;9(7):7534-7540. doi: 10.18632/oncotarget.23691. eCollection 2018 Jan 26.

41.

Lymphomatoid granulomatosis and large granular lymphocyte leukemia, a rare association of two lymphoproliferative disorders.

De Luca G, Trasarti S, Bizzoni L, Del Giudice I, Della Starza I, De Propris MS, Gentile G, Mancini F, Mantovani S, Petrucci L, Tabanelli V, Guarini A, Vignetti M, Foà R.

Leuk Lymphoma. 2018 Nov;59(11):2715-2718. doi: 10.1080/10428194.2018.1439583. Epub 2018 Feb 23. No abstract available.

PMID:
29473430
42.

Genetic landscape of ultra-stable chronic lymphocytic leukemia patients.

Raponi S, Del Giudice I, Marinelli M, Wang J, Cafforio L, Ilari C, Piciocchi A, Messina M, Bonina S, Tavolaro S, Bordyuh M, Mariglia P, Peragine N, Mauro FR, Chiaretti S, Molica S, Gentile M, Visentin A, Trentin L, Rigolin GM, Cuneo A, Diop F, Rossi D, Gaidano G, Guarini A, Rabadan R, Foà R.

Ann Oncol. 2018 Apr 1;29(4):966-972. doi: 10.1093/annonc/mdy021.

43.

A Comparative Assessment of Quality of Life in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Through an Outpatient and Inpatient Model.

Martino M, Ciavarella S, De Summa S, Russo L, Meliambro N, Imbalzano L, Gallo GA, Moscato T, Messina G, Ferreri A, Cuzzola M, Irrera G, Naso V, Cimminiello M, Console G, Loseto G, Tommasi S, Guarini A.

Biol Blood Marrow Transplant. 2018 Mar;24(3):608-613. doi: 10.1016/j.bbmt.2017.09.021. Epub 2017 Oct 13.

44.

Timing and deepness of response to tyrosine kinase inhibitors as a measure of potential treatment discontinuation in chronic myeloid leukemia patients managed in the real-life.

Breccia M, Colafigli G, Molica M, Scalzulli E, Diverio D, Latagliata R, Guarini A, Foà R.

Am J Hematol. 2017 Dec;92(12):E668-E670. doi: 10.1002/ajh.24916. Epub 2017 Oct 19. No abstract available.

45.

Clinical relevance of silent red blood cell autoantibodies.

Mauro FR, Trastulli F, Alessandri C, Valesini G, Giovannetti G, Riemma C, Porrazzo M, Pepe S, Colafigli G, Caputo MD, De Propris MS, Guarini AR, Girelli G, Coluzzi S, Foà R.

Haematologica. 2017 Dec;102(12):e473-e475. doi: 10.3324/haematol.2017.177675. Epub 2017 Sep 21. No abstract available.

46.

Refined karyotype-based prognostic stratification of chronic lymphocytic leukemia with a low- and very-low-risk genetic profile.

Giudice ID, Rigolin GM, Raponi S, Cafforio L, Ilari C, Wang J, Bordyuh M, Piciocchi A, Marinelli M, Nanni M, Tavolaro S, Filetti M, Bardi A, Tammiso E, Volta E, Negrini M, Saccenti E, Mauro FR, Rossi D, Gaidano G, Guarini A, Rabadan R, Cuneo A, Foà R.

Leukemia. 2018 Feb;32(2):543-546. doi: 10.1038/leu.2017.292. Epub 2017 Sep 19. No abstract available.

47.

Improving Provision of Care for Long-term Survivors of Lymphoma.

Ciavarella S, Minoia C, Quinto AM, Oliva S, Carbonara S, Cormio C, Cox MC, Bravo E, Santoro F, Napolitano M, Spina M, Loseto G, Guarini A.

Clin Lymphoma Myeloma Leuk. 2017 Dec;17(12):e1-e9. doi: 10.1016/j.clml.2017.08.097. Epub 2017 Aug 17. Review.

PMID:
28916153
48.

Pharmacologic or Genetic Targeting of Glutamine Synthetase Skews Macrophages toward an M1-like Phenotype and Inhibits Tumor Metastasis.

Palmieri EM, Menga A, Martín-Pérez R, Quinto A, Riera-Domingo C, De Tullio G, Hooper DC, Lamers WH, Ghesquière B, McVicar DW, Guarini A, Mazzone M, Castegna A.

Cell Rep. 2017 Aug 15;20(7):1654-1666. doi: 10.1016/j.celrep.2017.07.054.

49.

Object exploration in extremely preterm infants between 6 and 9 months and relation to cognitive and language development at 24 months.

Zuccarini M, Guarini A, Savini S, Iverson JM, Aureli T, Alessandroni R, Faldella G, Sansavini A.

Res Dev Disabil. 2017 Sep;68:140-152. doi: 10.1016/j.ridd.2017.06.002. Epub 2017 Aug 3.

PMID:
28779627
50.

Association between proteomic profile and molecular response in chronic myeloid leukemia patients.

Garrisi VM, Sgherza N, Breccia M, Iacobazzi A, De Tullio G, Nardelli G, Negri A, Divella R, Daniele A, Micelli G, Tufaro A, Cascavilla N, Savino E, Abbate I, Guarini A.

Leuk Lymphoma. 2018 Apr;59(4):1016-1018. doi: 10.1080/10428194.2017.1344841. Epub 2017 Jul 11. No abstract available.

PMID:
28695760

Supplemental Content

Loading ...
Support Center